Defining optimal immunotherapies for type 1 diabetes.

Bibliographic Details
Corporate Author:	Novartis Foundation
Format:	Book
Language:	English
Published:	Chichester, U.K. ; Hoboken, N.J. : Wiley-Blackwell, 2008.
Series:	Novartis Foundation symposium ; 292.
Subjects:	Diabetes > Immunotherapy > Congresses. Diabetes Mellitus > immunology. Diabetes Mellitus > therapy. Congresses.

Remote Storage